Literature DB >> 30639167

A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomas.

Heather Minto1, Kofi A Mensah2, Paul R Reynolds1, Eric Meffre2, Kira Rubtsova3, Erwin W Gelfand4.   

Abstract

Ataxia-Telangiectasia (AT) is an immunodeficiency most often associated with T cell abnormalities. We describe a patient with a hyper-IgM phenotype and immune cell abnormalities that suggest a distinct clinical phenotype. Significant B cell abnormalities with increased unswitched memory B cells, decreased naive transitional B cells, and an elevated frequency of CD19+CD38loCD27-CD10-CD21-/low B cells expressing high levels of T-bet and Fas were demonstrated. The B cells were hyporesponsive to in vitro stimulation through the B cell receptor, Toll like receptors (TLR) 7 and 9, and CD40. T cell homeostasis was also disturbed with a significant increase in γδ T cells, circulating T follicular helper cells (Tfh), and decreased numbers of T regulatory cells. The ATM mutations in this patient are posited to have resulted in the perturbations in the frequencies and distributions of B and T cell subsets, resulting in the phenotype in this patient. KEY MESSAGES: A novel mutation creating a premature stop codon and a nonsense mutation in the ATM gene are postulated to have resulted in the unique clinical picture characterized by abnormal B and T cell populations, lymphocyte subset dysfunction, granuloma formation, and a hyper-IgM phenotype. CAPSULE
SUMMARY: A patient presented with ataxia-telangiectasia, cutaneous granulomas, and a hyper-IgM phenotype; a novel combination of mutations in the ATM gene was associated with abnormal distributions, frequencies, and function of T and B lymphocyte subsets.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ataxia-telangiectasia; CD38(lo)CD21(−/low) B cells; Fas; Hyper-IgM; T-bet; Tfh; Tregs; γδ T cells

Mesh:

Substances:

Year:  2019        PMID: 30639167      PMCID: PMC7027322          DOI: 10.1016/j.clim.2019.01.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  50 in total

1.  Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.

Authors:  Martin S Naradikian; Arpita Myles; Daniel P Beiting; Kenneth J Roberts; Lucas Dawson; Ramin Sedaghat Herati; Bertram Bengsch; Susanne L Linderman; Erietta Stelekati; Rosanne Spolski; E John Wherry; Christopher Hunter; Scott E Hensley; Warren J Leonard; Michael P Cancro
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

2.  Infliximab in the treatment of a child with cutaneous granulomas associated with ataxia telangiectasia.

Authors:  Angana Mitra; Jimmy Gooi; Jonathan Darling; Julia A Newton-Bishop
Journal:  J Am Acad Dermatol       Date:  2011-09       Impact factor: 11.527

3.  CVID-associated TACI mutations affect autoreactive B cell selection and activation.

Authors:  Neil Romberg; Nicolas Chamberlain; David Saadoun; Maurizio Gentile; Tuure Kinnunen; Yen Shing Ng; Manmeet Virdee; Laurence Menard; Tineke Cantaert; Henner Morbach; Rima Rachid; Natalia Martinez-Pomar; Nuria Matamoros; Raif Geha; Bodo Grimbacher; Andrea Cerutti; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

Review 4.  The genetic defect in ataxia-telangiectasia.

Authors:  M F Lavin; Y Shiloh
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.

Authors:  Mirzokhid Rakhmanov; Baerbel Keller; Sylvia Gutenberger; Christian Foerster; Manfred Hoenig; Gertjan Driessen; Mirjam van der Burg; Jacques J van Dongen; Elisabeth Wiech; Marcella Visentini; Isabella Quinti; Antje Prasse; Nadine Voelxen; Ulrich Salzer; Sigune Goldacker; Paul Fisch; Hermann Eibel; Klaus Schwarz; Hans-Hartmut Peter; Klaus Warnatz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-29       Impact factor: 11.205

6.  ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells.

Authors:  Lukas Bossaller; Jan Burger; Ruth Draeger; Bodo Grimbacher; Rolf Knoth; Alessandro Plebani; Anne Durandy; Ulrich Baumann; Michael Schlesier; Andrew A Welcher; Hans Hartmut Peter; Klaus Warnatz
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

7.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.

Authors:  Rimpei Morita; Nathalie Schmitt; Salah-Eddine Bentebibel; Rajaram Ranganathan; Laure Bourdery; Gerard Zurawski; Emile Foucat; Melissa Dullaers; SangKon Oh; Natalie Sabzghabaei; Elizabeth M Lavecchio; Marilynn Punaro; Virginia Pascual; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2011-01-06       Impact factor: 31.745

Review 8.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

9.  B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis.

Authors:  Alexander Schwarz; Bettina Balint; Mirjam Korporal-Kuhnke; Sven Jarius; Kathrin von Engelhardt; Alexandra Fürwentsches; Cornelia Bussmann; Friedrich Ebinger; Brigitte Wildemann; Jürgen Haas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-15

10.  Common Variable Immunodeficiency and Circulating TFH.

Authors:  Ana Coraglia; Nora Galassi; Diego S Fernández Romero; M Cecilia Juri; Marta Felippo; Alejandro Malbrán; María M E de Bracco
Journal:  J Immunol Res       Date:  2016-03-16       Impact factor: 4.818

View more
  6 in total

1.  CD21- CD27- Atypical B Cells in a Pediatric Cohort Study: An Extensive Single Center Flow Cytometric Analysis.

Authors:  Francesco Corrente; Sara Terreri; Patrizia Palomba; Claudia Capponi; Mattia Mirabella; Carlo Federico Perno; Rita Carsetti
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

2.  Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.

Authors:  Amarilla B Mandola; Brenda Reid; Raga Sirror; Rae Brager; Peter Dent; Pranesh Chakroborty; Dennis E Bulman; Chaim M Roifman
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

3.  Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia.

Authors:  Anna K Meyer; Mindy Banks; Tibor Nadasdy; Jennifer J Clark; Rui Zheng; Erwin W Gelfand; Jordan K Abbott
Journal:  Front Pediatr       Date:  2019-10-24       Impact factor: 3.418

4.  Granulomatous Liver Disease in Ataxia-Telangiectasia With the Hyper-IgM Phenotype: A Case Report.

Authors:  Aleksandra Szczawińska-Popłonyk; Lidia Ossowska; Katarzyna Jończyk-Potoczna
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

5.  Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.

Authors:  Amit Rawat; Rahul Tyagi; Himanshi Chaudhary; Vignesh Pandiarajan; Ankur Kumar Jindal; Deepti Suri; Anju Gupta; Madhubala Sharma; Kanika Arora; Amanjit Bal; Priyanka Madaan; Lokesh Saini; Jitendra Kumar Sahu; Yumi Ogura; Tamaki Kato; Kohsuke Imai; Shigeaki Nonoyama; Surjit Singh
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

6.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.